Abbott signs $400 million deal with Reata
December 13, 2011Research and Development, Sales and Marketing Abbott
Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …
Pfizer awaits verdict on contaminated site clean-up plan
December 13, 2011Manufacturing and Production, Sales and Marketing FDA, Pfizer, manufacturing
The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …
Katherine Baicker elected to Lilly’s board of directors
December 12, 2011Business Services, Research and Development, Sales and Marketing lilly
Lilly has elected Katherine Baicker as a new member of its board of directors, effective immediately. Baicker, 40, is Professor …
New report highlights postcode lottery for medicines
December 12, 2011DoH, NHS, UK
A new report by the Department of Health illustrates a stark postcode lottery in drug spend for patients with chronic …
GSK’s Tyverb fails late-stage trial in breast cancer
December 12, 2011Research and Development, Sales and Marketing GSK, Tyverb, breast cancer
GlaxoSmithKline’s Tyverb has failed to help women with HER2 positive breast cancer increase their survival. The TEACH study’s primary objective …
Who’s really in charge of the new NHS?
December 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS reform
Each year the health service, the Department of Health and the UK pharmaceutical industry get an opportunity to say what …
EMA and FDA move closer on inspections
December 12, 2011Manufacturing and Production EMA, FDA
The EMA and US FDA has taken a step closer to mutual recognition of manufacturing site inspections, launching a three-year …
Janssen inks $150m deal for blood cancer drug
December 12, 2011Research and Development, Sales and Marketing Janssen, Pharmacyclics
Janssen biotech has signed a licensing deal with Pharmacyclics for its investigational blood cancer drug. The firm has paid $150 …
SHL receives great response at the 2011 PDA in Basel
December 12, 2011Manufacturing and Production autoinjector, pda, pen injector, prefilled syringe, shl group
SHL successfully wrapped up this year’s exhibition at the PDA’s ” The Universe of Pre-filled Syringes and Injection Devices” 2011 …
Takeda’s blood pressure treatment Edarbi approved
December 9, 2011Sales and Marketing Diovan, Eisai, cardiovascular, high blood pressure, hypertension
Takeda’s new hypertension treatment Edarbi has been approved in Europe.Edarbi (azilsartan medoxomil) is a new once-daily angiotensin receptor blocker (ARB) …
Succinct Communications makes three appointments
December 9, 2011Business Services, Medical Communications, Sales and Marketing Succinct
Succinct Communications has appointment a number of new staff members to support the growth of its organisation. Chris Stevenson joins …
Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals
December 9, 2011Manufacturing and Production, Research and Development FDA Approval
Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …
Erectile dysfunction drugs restricted on NHS
December 9, 2011Sales and Marketing Cialis, ED, Levitra, NHS, PCTs, viagra
Health authorities in England are restricting the use of erectile dysfunction drugs to help cut costs. Pfizer’s Viagra, Lilly’s Cialis …
Novartis warned over standards at generics sites
December 9, 2011Manufacturing and Production CGMP Failures, FDA compliance, Novartis, Sandoz
The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …
Dr Rajeev Venkayya to head Takeda’s new vaccine business
December 9, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda
Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …
Roche’s new breast cancer drug succeeds in late-stage trial
December 9, 2011Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab
Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …
NICE rejects Merck’s COPD drug Daxas
December 9, 2011Sales and Marketing COPD, Daxas, Merck, Nycomed
NICE has not recommended Merck’s COPD drug Daxas and is asking for a new clinical trial to test its effectiveness. …
NHS to collaborate with pharma on innovation
December 8, 2011Sales and Marketing ABPI, NHS, NHS Confederation, collaboration
The NHS Confederation is to hold a series of strategic meetings with the pharma industry and the medical technology industries …
Europeans keen on medicines info – but not via Facebook or Twitter
December 8, 2011Medical Communications Digital Blog, Facebook
A new survey finds demand for information on medicines is strong in Europe, but consumers aren’t using social sites such …
AstraZeneca to cut 1,150 staff in the US
December 8, 2011Research and Development, Sales and Marketing AstraZeneca, cuts
AstraZeneca will cut around 1,150 positions in the US as large patent expiries loom. The cuts will come primarily from …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
